新医改对我国医药产业的影响及政策建议 【摘要】截止至 2019 年底，新医改已经走过了近 10 年的路程，进入了医改的深水区。在这十年里新医改对我国医药产业的发展有着举足轻重的影响，对产业内价格体系的完善、医药物流的信息化、医药创新的积极性、市场容量的扩充以及产业集中度的提高都带来了积极的推进作用。为新医改能走好深水区第一步，更好地促进医药产业发展，提出了以下政策建议：1.对药品价格的调控要合理适度，维续企业发展的可持续性；2.给予企业政策性扶持，加快产业集中度提升；3.确保国有企业和私营企业的公平竞争。 【关键词】新医改；医药产业；政策建议注：本论文（设计）题目来源于教师的国家级（或省部级、厅级、市级、校级、企业）科研项目，项目编号为： 。The impact of new medical reform on China's pharmaceutical industry and policy suggestions [Abstract] By the end of 2019, the new medical reform has gone through nearly 10 years and entered the deep water area of medical reform. In the past decade, the new medical reform has a significant impact on the development of China's pharmaceutical industry. It has brought positive promotion to the improvement of the price system in the industry, the informatization of pharmaceutical logistics, the enthusiasm of pharmaceutical innovation, the expansion of market capacity and the improvement of industrial concentration. In order to take the first step of the new medical reform in the deep water area and promote the development of the pharmaceutical industry better, the following policy suggestions are put forward: 1. The regulation and control of drug prices should be reasonable and appropriate to maintain the sustainability of the development of enterprises; 2. Policy support should be given to enterprises to accelerate the upgrading of industrial concentration; 3. Fair competition between state-owned enterprises and private enterprises should be ensured. [Key words] new ...
